Oklahoma City, OK – According to filings with the U.S. Securities and Exchange Commission, Wheeler Bio is raising $30,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jesse Mccool played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Wheeler Bio
A disruptive new biopharmaceutical CDMO, we are pushing the boundaries of biomanufacturing and solving an outdated industry bottleneck with a unique partnering model. By bringing together biologics drug innovators, discovery CROs, and CDMOs, we are accelerating the translation of therapeutic innovation to clinical impact.

To learn more about Wheeler Bio, visit http://www.wheelerbio.com/

Contact:
Jesse Mccool, Chief Executive Officer
405-279-6767
https://www.linkedin.com/in/jessemccool/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved